Rice Bran Compound May Help Regulate Intestinal Movement by Inhibiting Calcium Channels

Research reveals that ferulic acid from rice bran can regulate intestinal contractions by blocking calcium channels, offering new potential treatments for gastrointestinal disorders.
A recent study conducted by researchers at Toho University has identified ferulic acid (FA), a natural compound abundant in rice bran, as a potential modulator of intestinal motility. The research demonstrates that FA can suppress intestinal smooth muscle contractions by blocking voltage-dependent calcium channels, which are crucial for muscle activity in the gut. This finding opens promising avenues for dietary strategies aimed at managing gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). The study involved experiments on guinea pig ileal smooth muscle, revealing that FA effectively and reversibly reduced contractions triggered by neurotransmitters like acetylcholine, histamine, prostaglandin F2α, and serotonin. Further tests indicated that FA also lowered intracellular calcium levels in vascular smooth muscle cells, confirming its action on calcium channels. Although the concentrations used in the study were higher than typical dietary intake, the results suggest that oral consumption of FA-rich foods like rice bran could influence gut motility, especially since intestinal concentrations may be elevated after ingestion. This research, published in the Journal of Pharmacological Sciences, underscores the potential of ferulic acid as a natural agent for regulating intestinal movements, possibly providing relief for symptoms associated with excessive smooth muscle activity. Future clinical trials are needed to determine safe and effective doses for human applications.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Combination Therapy Shows Promise for Advanced Triple-Negative Breast Cancer
A groundbreaking clinical trial demonstrates that combining sacituzumab govitecan with pembrolizumab offers improved outcomes for patients with advanced PD-L1-positive triple-negative breast cancer, potentially revolutionizing first-line treatment options.
Innovative Approach Predicts Resistance to Bowel Cancer Treatments, Aiding Development of Smarter Drugs
Researchers from London have developed a groundbreaking tool that predicts how bowel cancer cells develop resistance to treatment, paving the way for personalized and more effective therapies. This innovation could significantly improve long-term outcomes for patients with this common cancer.
Household Mold as a Significant Cause of Hypersensitivity Pneumonitis
Indoor mold exposure significantly contributes to hypersensitivity pneumonitis, a serious lung disease. New research highlights the importance of environmental assessments and mold removal for patient health.
Wildfires and Their Impact on Increasing Risks of Flu and COVID-19 Spread
Wildfires may increase the risk of flu and COVID-19 outbreaks by driving more people indoors, where airborne diseases can spread more easily. Wearing masks can help reduce this risk during wildfire seasons.